SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Change in Working Capital

Cash absorbed or released by changes in receivables, inventory, payables, and other operating balances.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Change in Working Capital · Q1 FY2026 · quarter ended Mar 2026

Change in working capital of -$1.75M in Q1 FY2026

Q1 FY2026 change in working capital was -$1.75M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$1.75M-168.4% QoQ
Last fiscal yearDec 2025
$2.45M— YoY
Change in Working Capital past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Change in Working Capital history

USD · from the cash flow

Latest · FY2025
2.45M USD
Year-over-year change
—

Change in Working Capital vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so change in working capital is compared through growth and share of revenue rather than absolute size.
SGP Competitors
Change in Working Capital for SGP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ALCAlcon Inc.LTM Sep 2026$352.66M USD+21.4%-22.8%3.2%
STAASTAAR Surgical CompanyLTM Apr 2026$88.42M USD-341.8%-17.5%30.4%
BLCOBausch + Lomb CorporationLTM Jun 2026$57.85M USD+60.7%—1.1%
EYPTEyePoint Pharmaceuticals, Inc.LTM Mar 2026$26.49M USD+1949.9%+123.6%347.8%
GKOSGlaukos CorporationLTM Jun 2026$6.89M USD-82.4%+32.9%1.1%
OCULOcular Therapeutix, Inc.LTM Mar 2026$3.14M USD-62.2%+78.8%6.0%
SGPSpyGlass Pharma, Inc. Common StockFY2025$2.45M USD———
OCSOculis Holding AGLTM Mar 2026CHF 1.95M CHF-85.9%—386.6%
SGHTSight Sciences, Inc.LTM Mar 2026$1.06M USD-194.1%+3.9%1.3%
RXSTRxSight, Inc.LTM Mar 2026$676K USD-93.7%-12.9%0.5%
Peer median (excluding SGP) —-82.4%+3.9%3.2%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.